About Pricing FAQs Providers Trials Blog

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? [email protected]

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Intravitreal Bevacizumab for Neovascular Glaucoma

NCT00384631·1 site·ClinicalTrials.gov

What this study is about

Take this into the appointment.

Saves the questions and what to expect into your notes, next to the visit they belong to.

Keep this study

Lead

Shahid Beheshti University of Medical Sciences

Age

10–80

Sex

ALL

Healthy volunteers

Not accepted

You may be eligible if

Clinical diagnosis of NVG
Vision less than 20/200
age 10-80 years

You may not be if

Uncontrolled Blood Pressure
History of thromboembolism
Congestive Heart Failure
Renal Failure
Pregnancy or Lactation
Active ocular or periocular infection
No light perception

The record

StatusCompleted

PhaseNo phase

Taking part26

StartedApr 2006

UpdatedFeb 15, 2008

Conditions

Neovascular Glaucoma

Where1

Labbafinejad Medical Center
Tehran, Tehran Province, Iran

Clareo Health | Intravitreal Bevacizumab for Neovascular Glaucoma